TY - JOUR
T1 - A case of curatively resected intrahepatic cholangiocarcinoma with hepatic artery and portal vein reconstruction
AU - Matsuura, Yusuke
AU - Wada, Hiroshi
AU - Tomimaru, Yoshito
AU - Tomokuni, Akira
AU - Hama, Naoki
AU - Kawamoto, Koichi
AU - Kobayashi, Shogo
AU - Marubashi, Shigeru
AU - Eguchi, Hidetoshi
AU - Umeshita, Koji
AU - Doki, Yuichiro
AU - Mori, Masaki
AU - Nagano, Hiroaki
PY - 2014/11
Y1 - 2014/11
N2 - We report a case of curatively resected intrahepatic cholangiocarcinoma (ICC) with hepatic artery (HA) and portal vein (PV) reconstruction. A 25-year-old man was diagnosed with ICC. Computed tomography (CT) showed that the tumor had invaded the left and common hepatic duct, the right and left HA, and the main branch of the PV. Because the posterior HA was tumor free, we performed a left trisegmentectomy, PV and HA resection and reconstruction, and a hepatocholangiojejunostomy. Pathological examination revealed a tumor classification of T3, N1, MO, Stage IVB. The patient was discharged on postoperative day 59 and gemcitabine (1,000 mg/m2) was administered as adjuvant chemotherapy. However, abdominal CT revealed peritoneal metastasis 8 months after the surgery. A gemcitabine, cisplatin, and TS-1 (GCS) regimen was selected as treatment, and the patient is alive 13 months after surgery.
AB - We report a case of curatively resected intrahepatic cholangiocarcinoma (ICC) with hepatic artery (HA) and portal vein (PV) reconstruction. A 25-year-old man was diagnosed with ICC. Computed tomography (CT) showed that the tumor had invaded the left and common hepatic duct, the right and left HA, and the main branch of the PV. Because the posterior HA was tumor free, we performed a left trisegmentectomy, PV and HA resection and reconstruction, and a hepatocholangiojejunostomy. Pathological examination revealed a tumor classification of T3, N1, MO, Stage IVB. The patient was discharged on postoperative day 59 and gemcitabine (1,000 mg/m2) was administered as adjuvant chemotherapy. However, abdominal CT revealed peritoneal metastasis 8 months after the surgery. A gemcitabine, cisplatin, and TS-1 (GCS) regimen was selected as treatment, and the patient is alive 13 months after surgery.
UR - http://www.scopus.com/inward/record.url?scp=84949194653&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949194653&partnerID=8YFLogxK
M3 - Article
C2 - 25731431
AN - SCOPUS:84949194653
VL - 41
SP - 2086
EP - 2088
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
SN - 0385-0684
IS - 12
ER -
